fda glp-1 news november 2025 warning The FDA has approved the first GLP-1 pill Lilly, chasing Novo, expects second-quarter

The peptide is considered a potential research candidate in studies of major depressive disorder

It helps make your skin naturally brighter and more even, often by 1-2 shades, by reducing dark pigments

Finally, the review addresses the broader implications of these findings for geroscience and outlines future directions for investigating the potential of GLP-1 RAs in healthspan extension, while also acknowledging the limitations and potential biases inherent in this analytical review

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the management of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities

Youll be surprised by which stars GLP-1 reveal was followed by the biggest spike in appointments See more of our coverage in your search results

13 Months: Nerve Healing and Full Recovery Over the next one to three months, deeper healing happens